Waypoint BioWaypoint Bio — Spatial Pooled Screening & AI Design

Waypoint Bio leverages artificial intelligence, computer vision, and spatial pooled screening to engineer next-generation T cell therapies for solid tumors. The proprietary platform enables in vivo testing of thousands of cell therapy designs simultaneously, measuring hundreds of phenotypes at the single cell level to rank and optimize designs for safer, more effective therapies.

The platform compresses years of traditional drug discovery work into a single experiment, allowing researchers to rank and optimize cell therapy designs. Wayfinder LLM learns from data to suggest new designs, creating a closed loop of design, test, and optimization.